Background: Processes that regulate inflammatory changes that contribute to the development of diabetic retinopathy are not known. Results: Hyperglycemia increases histone acetylation, and HAT and HDAC inhibit this acetylation and induction of inflammatory proteins in retina. Conclusion: Protein acetylation regulates the hyperglycemia-induced up-regulation of proinflammatory proteins. Significance: Identification of acetylation as a regulator of proinflammatory processes in diabetes offers new therapeutic targets to inhibit the retinopathy.